Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastoma
about
Transactivation of Epidermal Growth Factor Receptor by G Protein-Coupled Receptors: Recent Progress, Challenges and Future ResearchChallenges to targeting epidermal growth factor receptor in glioblastoma: escape mechanisms and combinatorial treatment strategiesLong-term survival in a patient with glioblastoma on antipsychotic therapy for schizophrenia: a case report and literature reviewDopamine receptor D2 is correlated with gastric cancer prognosis.Epigenetic suppression of EGFR signaling in G-CIMP+ glioblastomas.USP9X inhibition promotes radiation-induced apoptosis in non-small cell lung cancer cells expressing mid-to-high MCL1Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression dataOrthogonal targeting of EGFRvIII expressing glioblastomas through simultaneous EGFR and PLK1 inhibition.Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expression.Differential localization of glioblastoma subtype: implications on glioblastoma pathogenesis.RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model.Inhibition of Dopamine Receptor D4 Impedes Autophagic Flux, Proliferation, and Survival of Glioblastoma Stem Cells.IDH mutation and MGMT promoter methylation in glioblastoma: results of a prospective registry.Discovery and clinical introduction of first-in-class imipridone ONC201.PREX1 integrates G protein-coupled receptor and phosphoinositide 3-kinase signaling to promote glioblastoma invasion.Advances and challenges in the search for D2 and D3 dopamine receptor-selective compounds.The potential roles of dopamine in malignant glioma.Association between tumor architecture derived from generalized Q-space MRI and survival in glioblastoma.Neuronal Activity in Ontogeny and Oncology.Sigma1 Pharmacology in the Context of Cancer.Cancer Immune Equilibrium and Schizophrenia Have Similar Interferon-γ, Tumor Necrosis Factor-α, and Interleukin Expression: A Tumor Model of Schizophrenia.Neuronal activity in the glioma microenvironment.A phase 2 study of the first imipridone ONC201, a selective DRD2 antagonist for oncology, administered every three weeks in recurrent glioblastoma.Role of Dopamine Receptors in the Anticancer Activity of ONC201.Monoamines in Glioblastoma: complex biology with therapeutic potential.Paired related homeobox 1 transactivates dopamine D2 receptor to maintain propagation and tumorigenicity of glioma-initiating cells.The critical role that STAT3 plays in glioma-initiating cells: STAT3 addiction in glioma.An Active Role for Neurons in Glioma Progression: Making Sense of Scherer's Structures.
P2860
Q26771727-478E93EF-3977-40FB-9F28-97C6FCC08411Q26852366-A21CD547-7B72-488E-B4DE-DF6C33A90299Q28069940-86F205BB-ED05-4BC4-9103-5F0697B3FD5EQ33599147-FB74ACD8-6013-4199-A071-812CC5B2E21BQ34365668-2DEE19CD-E7B6-4684-A62E-34F9976185CAQ35563248-9F420CC7-1265-44F9-8178-3058DA0FAC64Q35624037-BA96BB2A-F6A1-41D0-8083-9AFCBA2A403EQ35828426-2F664DDA-5CEE-4E53-AB1E-CBF543325AA1Q35910268-ABBC3493-9DC5-4635-BE67-BE7EA117E32EQ35983265-2B055FA4-4DA5-4D21-8CA5-675C32641655Q36020835-7D1B207C-8503-4AC7-8D16-8C1CD27E875DQ36051827-B57B39BD-B7D0-49CC-9CAB-84F1F8E162D8Q36562205-1488A516-F08F-4AFB-AA4D-D8292B1A1056Q37687570-A1FE13D3-ADD2-47C9-B3D0-F3E1A92B0798Q37702754-5EB73DD0-AEEB-4BB8-BCAA-80848A9D10C0Q38656262-86EFC3CA-D682-411A-B17E-5767493FDA24Q38780472-318F54E4-80EF-44A2-950A-A4D3DBB92BFEQ38839352-DFF10E7F-A0E2-46E6-84E4-83810B03336FQ39441395-68C75AA7-C8BE-4233-9C51-B61CA95AE818Q39458668-503246C6-6F11-4184-8A6E-F978A8FF8E7AQ42650181-64B49C1F-1C98-4A33-87BF-DB71ED99C608Q45985236-D29C2A94-A0D3-4EB5-9D5A-7040E281CA47Q47136169-F07023B0-4629-4297-A0EF-25323BD10AE4Q47136932-4BB61873-4599-40AA-B0F0-89D42CF9CC66Q47617131-93CED6A3-3A78-4369-B468-E4C70C3A7376Q50645523-C7786179-C66C-4411-BDF3-F8977F22612DQ55283055-62FA36CD-C280-4AF4-AF6F-BC05959FDC89Q55457014-BFBD8B2A-5A5E-48EE-A2A0-F3AC8AA9306D
P2860
Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastoma
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Genome-wide shRNA screen revea ...... eceptor (EGFR) in glioblastoma
@ast
Genome-wide shRNA screen revea ...... eceptor (EGFR) in glioblastoma
@en
Genome-wide shRNA screen revea ...... g between dopamine receptor D2
@nl
type
label
Genome-wide shRNA screen revea ...... eceptor (EGFR) in glioblastoma
@ast
Genome-wide shRNA screen revea ...... eceptor (EGFR) in glioblastoma
@en
Genome-wide shRNA screen revea ...... g between dopamine receptor D2
@nl
prefLabel
Genome-wide shRNA screen revea ...... eceptor (EGFR) in glioblastoma
@ast
Genome-wide shRNA screen revea ...... eceptor (EGFR) in glioblastoma
@en
Genome-wide shRNA screen revea ...... g between dopamine receptor D2
@nl
P2093
P2860
P356
P1433
P1476
Genome-wide shRNA screen revea ...... eceptor (EGFR) in glioblastoma
@en
P2093
Bob S Carter
Chang-Hyuk Kwon
Clark C Chen
David Kozono
Deepa Kushwaha
Diahnn Futalan
Johnny C Akers
Kimberly Ng
Michael Schlabach
P2860
P304
P356
10.18632/ONCOTARGET.1801
P407
P577
2014-02-01T00:00:00Z